Medicament for treating pelvic inflammation

A technology for pelvic inflammatory disease and drugs, which is applied in the direction of drug combinations, medical formulas, plant raw materials, etc., can solve the problems of no basis for treating diseases, poor clinical effects, and high treatment costs, and achieves no toxic side effects, low price, and long-term treatment. short effect

Inactive Publication Date: 2011-04-13
句容市边城卫生院
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Clinically, many people think that pelvic inflammatory disease is mostly caused by damp-heat pathogens, so the methods of clearing away heat and dampness, removing blood stasis and relieving pain are blindly given, without following the principle of seeking the root of the disease, and the effect i

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating pelvic inflammation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Embodiment 1: a kind of medicine for the treatment of pelvic inflammatory disease, it comprises A side and B side, wherein

[0015] Party A is mainly made of the following raw materials: Evodia 5g, Angelica 10g, Chishao 10g, Chuanxiong 10g, Guizhi 5g, Ginger 10g, Danpi 10g, Chuanduan 5g, Eucommia 10g, Fried Wulingzhi 10g, Puhuang Charcoal 10g, licorice 10g;

[0016] Party B is mainly made of the following raw materials: red rattan 30g, Patrinia 30g, roasted cinnamon twig 10g, frankincense 10g, powdered medicine 10g, safflower 10g, coix seed 20g, atractylodes 15g, poria cocos 10g, toosendan 15g.

[0017] The usage method of the present invention:

[0018] 1. Decoction of side A in water orally, as follows:

[0019] Soak the raw materials in Party A in water for 15 minutes, preferably with water covering the surface of the medicine by 2cm, boil with strong fire, and fry with slow fire for 15-20 minutes, twice a day, take it warm, half an hour after meals take;

[0020...

Embodiment 2

[0023] Embodiment 2: substantially the same as embodiment 1, the difference is the formula,

[0024] Party A: Party A is mainly made of the following raw materials: Evodia 10g, Angelica 15g, Chishao 15g, Chuanxiong 5g, Guizhi 5g, Ginger 5g, Danpi 15g, Chuanduan 5g, Eucommia 15g, Fried Wulingzhi 15g, Puhuang Charcoal 15g, Licorice 5g;

[0025] Party B is mainly made of the following raw materials: 20g of red rattan, 20g of Patrinia, 15g of roasted cinnamon sticks, 15g of frankincense, 15g of powdered medicine, 15g of safflower, 30g of coix seed, 20g of atractylodes, 15g of poria cocos, and 10g of toosendan.

Embodiment 3

[0026] Embodiment 3: substantially the same as embodiment 1, the difference is the formula,

[0027] Party A: Evodia 8g, Angelica 12g, Chishao 12g, Chuanxiong 8g, Guizhi 8g, Ginger 8g, Danpi 12g, Chuanduan 8g, Eucommia 12g, Fried Wulingzhi 12g, Puhuang charcoal 12g, licorice 8g;

[0028] Party B: 25g of red rattan, 25g of Patrinia, 12g of roasted cinnamon sticks, 12g of frankincense, 12g of powdered medicine, 12g of safflower, 25g of coix seed, 18g of atractylodes atractylodes, 12g of poria cocos, 12g of toosendan.

[0029] The beneficial effects of the present invention will be described in detail below through clinical cases.

[0030] Select 100 patients according to the patient's condition to carry out systematic clinical observation, and the patients are randomly divided into a test group and a control group, 50 people in each group, and the test group is treated according to the prescription and method of use in Example 1; the control group is treated according to convent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating pelvic inflammation, which is prepared according to a formula A and a formula B, wherein the formula A comprises raw material medicaments including medcinal evodia fruit, Chinese angelica, red paeony root, szechuan lovage rhizome, cassia twig, ginger, cortex moutan, himalayan teasel root, eucommia bark, fried trogopterus dung, carbonized pollen typhae and liquoric root; and formula B comprises raw material medicaments including sargent gloryvine, dahurian patrinia herb, prepared cassia twig, frank incense, myrrh, safflower, coix seed, rhizoma atractylodis, Indian buead and szechwan Chinaberry fruit. The medicament has the advantages of short treatment period, quick effectiveness and high cure rate. In the invention, the used medicaments are cheap and free from toxic and side effects and suitable for treating symptoms, such as pain in lower abdomen, lumbosacral aching, overmuch and yellowish morbid leucorrhea with particular odor, dyspareunia and fatigue or aggravated fatigue with cold.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a medicine for treating pelvic inflammatory disease. Background technique [0002] Pelvic inflammatory disease refers to the general term for inflammatory lesions such as reproductive organs in the pelvic cavity and connective tissue around the pelvic cavity, pelvic cavity, and peritoneum. With the increase of the floating population and the openness of the concept of sex, the incidence of pelvic inflammatory disease increased rapidly. Unreasonable use of antibiotics leads to the continuous emergence of drug-resistant strains, and the cure rate of pelvic inflammatory disease shows a downward trend, which leads to the increasing incidence of chronic pelvic inflammatory disease. These patients generally have a long course of disease, often have recurrent attacks, and persist for several years. Although there is no worry about life, there is lifelong tiredness. People...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9068A61K36/8994A61P15/00A61K35/24
Inventor 王莲
Owner 句容市边城卫生院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products